Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) shares dropped 3.8% during trading on Wednesday following insider selling activity. The stock traded as low as $16.81 and last traded at $17.1590. Approximately 4,842,087 shares were traded during trading, a decline of 46% from the average daily volume of 8,888,751 shares. The stock had previously closed at $17.83.
Specifically, CEO Thomas M. Stepien sold 60,702 shares of the company's stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $14.79, for a total value of $897,782.58. Following the transaction, the chief executive officer owned 699,298 shares in the company, valued at approximately $10,342,617.42. This represents a 7.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CTO Constantin Ionel Stefan sold 28,812 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $14.79, for a total transaction of $426,129.48. Following the completion of the sale, the chief technology officer owned 804,518 shares of the company's stock, valued at approximately $11,898,821.22. The trade was a 3.46% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In other Amprius Technologies news, Director Kang Sun sold 67,796 shares of Amprius Technologies stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $14.79, for a total transaction of $1,002,702.84. Following the completion of the sale, the director owned 1,280,854 shares of the company's stock, valued at $18,943,830.66. This trade represents a 5.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on the stock. Cantor Fitzgerald upped their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the stock an "overweight" rating in a research note on Friday, March 6th. Craig Hallum boosted their target price on Amprius Technologies from $17.00 to $21.00 and gave the company a "buy" rating in a research note on Friday, March 6th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a research report on Monday, April 20th. B. Riley Financial raised their price target on Amprius Technologies from $16.00 to $22.00 and gave the stock a "buy" rating in a research note on Monday, March 9th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $20.00 price target on shares of Amprius Technologies in a research note on Tuesday, March 10th. Eight analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Amprius Technologies presently has an average rating of "Moderate Buy" and a consensus target price of $20.25.
Get Our Latest Research Report on AMPX
Amprius Technologies Stock Performance
The firm has a market cap of $2.43 billion, a price-to-earnings ratio of -57.19 and a beta of 2.20. The firm's 50 day moving average is $18.06 and its 200-day moving average is $13.62.
Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Amprius Technologies had a negative return on equity of 17.48% and a negative net margin of 43.98%.The business had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. As a group, research analysts predict that Amprius Technologies, Inc. will post -0.07 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE grew its holdings in Amprius Technologies by 31.1% during the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company's stock valued at $36,000 after purchasing an additional 3,055 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of Amprius Technologies by 86.7% during the 1st quarter. AQR Capital Management LLC now owns 77,764 shares of the company's stock worth $208,000 after buying an additional 36,116 shares during the period. Millennium Management LLC grew its stake in Amprius Technologies by 94.5% in the 1st quarter. Millennium Management LLC now owns 1,396,013 shares of the company's stock valued at $3,741,000 after buying an additional 678,442 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Amprius Technologies by 128.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 244,646 shares of the company's stock worth $656,000 after acquiring an additional 137,640 shares during the period. Finally, Rhumbline Advisers raised its holdings in Amprius Technologies by 61.1% in the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company's stock worth $42,000 after acquiring an additional 5,951 shares during the period. 5.04% of the stock is owned by institutional investors.
About Amprius Technologies
(
Get Free Report)
Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amprius Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.
While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.